High cholesterol, Treatment for high cholesterol, Lowering cholesterol, Lowering high cholesterol, Hypercholesterolemia
Showing 1 - 25 of >10,000
Hypercholesterolemia Trial in Edmonton (Kefir)
Completed
- Hypercholesterolemia
- Kefir
-
Edmonton, Alberta, CanadaUniversity of Alberta
Jan 11, 2023
Hypercholesterolemia Trial (ezetimibe (+) simvastatin, Comparator : rosuvastatin calcium, Comparator: Placebo (unspecified))
Completed
- Hypercholesterolemia
- ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 7, 2022
Hypercholesteremia, Ultrasound Therapy Trial in Nanjing (High-intensity focused ultrasound, Sham treatment)
Active, not recruiting
- Hypercholesteremia
- Ultrasound Therapy
- High-intensity focused ultrasound
- Sham treatment
-
Nanjing, Jiangsu, ChinaJiangSu Province Hospital / The First Affiliated Hospital of Nan
Oct 15, 2021
Chronic Kidney Diseases, High Cholesterol Trial in Mineola, New York (Evolocumab, Placebo)
Withdrawn
- Chronic Kidney Diseases
- High Cholesterol
- Evolocumab
- Placebo
-
Mineola, New York
- +1 more
Jul 27, 2022
Patients With High Cholesterol Levels Needing a Lipid-lowering Therapy Trial in Brussels (Genotyping)
Withdrawn
- Patients With High Cholesterol Levels Needing a Lipid-lowering Therapy
- Genotyping
-
Brussels, BelgiumSaint-Luc Hospital
Mar 16, 2021
Cholesterol Levels Trial in Alexandroupolis (Lacticaseibacillus with oats, Plain oats)
Active, not recruiting
- Cholesterol Levels
- Lacticaseibacillus with oats
- Plain oats
-
Alexandroupolis, East Macedonia And Thrace, GreeceDemocritus University of Thrace
Oct 25, 2023
Hypercholesterolemia, Insulin Resistance, Insulin Secretion Trial in Tuebingen (Lowering cholesterol concentrations by PCSK-9
Recruiting
- Hypercholesterolemia
- +2 more
- Lowering cholesterol concentrations by PCSK-9 inhibitor
-
Tuebingen, GermanyUniversity of Tuebingen, Department of Internal Medicine IV
Aug 24, 2022
LDL-cholesterol Trial in Jena (statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran)
Recruiting
- LDL-cholesterol
- statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
-
Jena, Thuringia, GermanyUniversity Hospital Jena
Oct 17, 2022
Lipid Metabolism Disorder Trial (Implementation Strategy Bundle, Usual care notification)
Not yet recruiting
- Lipid Metabolism Disorder
- Implementation Strategy Bundle
- Usual care notification
- (no location specified)
Jan 11, 2023
Patients With High Cholesterol and Normal Volunteers
Completed
- Homozygous Familial Hypercholesterolemic
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
To Reduce the LDL-C Level in Hypercholesteremia Adult Patients, Combination for Subgroup High LDL-c Patients With Other
Not yet recruiting
- To Reduce the LDL-C Level in Hypercholesteremia Adult Patients
- Combination for Subgroup High LDL-c Patients With Other Comorbidities
- RN0191 INJECTION
- (no location specified)
Jun 14, 2023
Hypercholesterolemia, Hyperlipidemias, Physical Inactivity Trial in Adelaide (Egg diet, Egg-free Diet, Control Diet)
Recruiting
- Hypercholesterolemia
- +3 more
- Egg diet
- +2 more
-
Adelaide, South Australia, AustraliaUniversity of South Australia Clinical Trial Facility
Mar 1, 2022
Hypercholesterolemia, Atherosclerotic Disease, Coronary Disease Trial (MK0653A , ezetimibe (+) simvastatin, Comparator:
Completed
- Hypercholesterolemia
- +2 more
- MK0653A , ezetimibe (+) simvastatin
- +2 more
- (no location specified)
Feb 3, 2022
Dyslipidemias, Cardiovascular Diseases, HIV Trial in San Francisco (Bempedoic acid, Placebo)
Not yet recruiting
- Dyslipidemias
- +3 more
- Bempedoic acid
- Placebo
-
San Francisco, CaliforniaSan Francisco General Hospital
Aug 3, 2022
Above Optimal Plasma LDL Concentrations Trial in Winnipeg, Toronto (muffin)
Active, not recruiting
- Above Optimal Plasma LDL Concentrations
- muffin
-
Winnipeg, Manitoba, Canada
- +1 more
Oct 24, 2022
Dyslipidemias, Hypercholesterolemia, Familial Hypercholesterolemia Trial (combination product, drug, other)
Not yet recruiting
- Dyslipidemias
- +4 more
- Combination Therapy
- +5 more
- (no location specified)
Aug 22, 2023
Type 1 Diabetes Trial in New York (Evolocumab Cartridge, Atorvastatin Calcium Tablets, Ezetimibe Tablets)
Recruiting
- Type 1 Diabetes
- Evolocumab Cartridge
- +6 more
-
New York, New York
- +2 more
Nov 29, 2022
High Cholesterol Trial in Indianapolis (5 mg rosuvastatin calcium with a Web App (combination product))
Active, not recruiting
- High Cholesterol
- 5 mg rosuvastatin calcium with a Web App (combination product)
-
Indianapolis, IndianaResearch Site
Jul 1, 2022
Hypercholesterolemia Trial (MK0653A, ezetimibe (+) simvastatin, Comparator: Rosuvastatin)
Completed
- Hypercholesterolemia
- MK0653A, ezetimibe (+) simvastatin
- Comparator: Rosuvastatin
- (no location specified)
Feb 3, 2022
Hypercholesterolemia Trial in Worldwide (inclisiran sodium, Placebo)
Active, not recruiting
- Hypercholesterolemia
- inclisiran sodium
- Placebo
-
Lanzhou, Gansu, China
- +44 more
Feb 7, 2022
ST Elevation Myocardial Infarction (STEMI) Trial (Rosuvastatin 20 mg, Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA])
Not yet recruiting
- ST Elevation Myocardial Infarction (STEMI)
- Rosuvastatin 20 mg
- Evolocumab 140 mg/1 ml Subcutaneous Solution [REPATHA]
- (no location specified)
Feb 1, 2023
Stress, Blood Sugar; High, Cholesterol, Elevated Trial in Los Angeles (7-Day Continuous Glucose Monitoring with Abbott Freestyle
Not yet recruiting
- Stress
- +3 more
- 7-Day Continuous Glucose Monitoring with Abbott Freestyle Libre 2
-
Los Angeles, CaliforniaUCLA Clinical Nutrition Clinic, 200 UCLA Medical Plaza, Suite 36
Aug 14, 2023
Cardiovascular Disease With Mention of Arteriosclerosis, Elevated Cholesterol, Familial Hypercholesterolemia Trial in Worldwide
Enrolling by invitation
- Cardiovascular Disease With Mention of Arteriosclerosis
- +2 more
-
Evanston, Illinois
- +11 more
Aug 6, 2021
Healthy Volunteers; High Cholesterol Trial in Los Angeles (NNC0385-0434 G, NNC0385-0434 F, NNC0385-0434 B)
Completed
- Healthy Volunteers; High Cholesterol
- NNC0385-0434 G
- +2 more
-
Cypress, California
- +1 more
Dec 19, 2022